Journal Article
Pharmacy Benefit Manager Market Concentration for Prescriptions Filled at US Retail Pharmacies
September 10, 2024
Featured Experts: Dima M. Qato, PharmD, MPH, PhD, Karen Van Nuys, PhD
Research
All Research Featured Research
Perspective
Responding to Some ‘Inconvenient’ Truths About PBMs
August 12, 2024
Featured Experts: Geoffrey Joyce, PhD
Perspective
State Mandates to Cap Out-of-Pocket Insulin Costs Are No Longer Necessary
August 5, 2024
Featured Experts: Dana Goldman, PhD
Evidence Base
A Patient-Focused, Evidence-Driven Approach to PBM Reform
July 22, 2024
Featured Experts: Karen Van Nuys, PhD, Dana Goldman, PhD, Stephanie Hedt, MPP, Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Neeraj Sood, PhD, Erin Trish, PhD
News
Schaeffer Center Researchers Make an Impact in Washington
April 25, 2024
Featured Experts: Darius Lakdawalla, PhD, Erin Trish, PhD, Karen Van Nuys, PhD, Neeraj Sood, PhD, Alice Chen, PhD
Issue Brief
A New Healthcare Valuation Model That Puts Patients First: Generalized Risk Adjusted Cost-Effectiveness (GRACE)
April 23, 2024
Featured Experts: Darius Lakdawalla, PhD, Stephanie Hedt, MPP, Barry Liden, JD
Perspective
Let the Market Determine Drug Prices – Not 19th Century Economics
April 22, 2024
Featured Experts: Dana Goldman, PhD
Perspective
Medicare Coverage of Weight Loss Drugs Could Save the U.S. Billions of Dollars
April 3, 2024
Featured Experts: Dana Goldman, PhD, Alison Sexton Ward, PhD
News
Medicare Part D Plans Increased Restrictions on Drug Coverage
March 4, 2024
Featured Experts: Geoffrey Joyce, PhD, Karen Van Nuys, PhD
Journal Article
Medicare Part D Plans Greatly Increased Utilization Restrictions On Prescription Drugs, 2011–20
March 4, 2024
Featured Experts: Geoffrey Joyce, PhD, Karen Van Nuys, PhD
Testimony
Testimony on Pharmaceutical Pricing That Balances Innovation and Affordability for Patients with Rare Diseases
February 29, 2024
Featured Experts: Alice Chen, PhD
Journal Article
A Principled Approach to Non‑Discrimination in Cost‑Effectiveness
February 27, 2024
Featured Experts: Darius Lakdawalla, PhD, Jason Doctor, PhD
Perspective
Knowing Actual Prices Will Help HHS Set the Maximum Fair Price under the Inflation Reduction Act
February 16, 2024
Featured Experts: Steve M. Lieberman, MPhil, MA, Paul Ginsburg, PhD
Testimony
Testimony on Ensuring Affordable and Valuable Pharmaceutical Innovation for Americans
February 8, 2024
Featured Experts: Darius Lakdawalla, PhD
Evidence Base
A Spoonful of Sugar Makes the Medicine Go Down
January 30, 2024
Featured Experts: Geoffrey Joyce, PhD
Comment Letter
Response to Sen. Cassidy’s Request for Information on Improving Americans’ Access to Gene Therapies
January 19, 2024
Featured Experts: Darius Lakdawalla, PhD, Joseph Grogan, JD, Stephanie Hedt, MPP, Barry Liden, JD, Erin Trish, PhD, Karen Van Nuys, PhD
Perspective
The Inflation Reduction Act’s Harms Go Beyond Drug Pricing — They’re Threatening Your Medicare
December 23, 2023
Featured Experts: Joseph Grogan, JD
Perspective
Biden’s Hepatitis C Initiative Needs Help from the Private Market
December 9, 2023
Featured Experts: Dana Goldman, PhD
Journal Article
Why Does the Inflation Reduction Act Exclude Expensive Cancer Treatments in Price Negotiations?
December 7, 2023
Featured Experts: Mireille Jacobson, PhD
Perspective
Want Lower Obesity Drug Costs? Medicare Holds the Key
November 21, 2023
Featured Experts: Dana Goldman, PhD